Serum Institute of India (SII), the world’s largest vaccine manufacturer by volume, Gavi, The Vaccine Alliance, a public-private global health partnership that aims to increase access to immunization in poor countries, and the Foundation Bill and Melinda Gates would accelerate the Manufacturing and delivery of up to 100 million doses …
Read More »
In a move to provide a potential Covid-19 vaccine, the world’s largest vaccine manufacturing company, the Serum Institute of India (SII), said today that it would raise an additional $ 150 million in funding from the Bill and Melinda Gates Foundation and the GAVI vaccine alliance to make an additional …
Read More »
PUNE: Adar Poonawalla, executive director of the Serum Institute of India (SII), which is producing the possible coronavirus vaccine developed by the University of Oxford, asked on Saturday if the government will have 80 billion rupees available to buy and distribute the vaccine . “Quick question: will the government of …
Read More »
NEW DELHI: The government may need ₹Rs 80 billion over the next year for the distribution of the covid-19 vaccine to all people in India, Serum Institute of India Executive Director Adar Poonawalla said on Saturday, calling it a “worrying challenge.” “Will the government of India have Rs 80 billion …
Read More »
Serum Institute of India has begun manufacturing the COVID-19 candidate vaccine developed by Codagenix Inc, the American biotech firm said in a statement. Nicknamed CDX-005, the coronavirus vaccine candidate has completed preclinical studies in animals. The company aims to begin the phase I clinical trial of its COVID-19 vaccine in …
Read More »
Phase III or last stage of the clinical trial of the Covid-19 ‘Covishield’ vaccine, which is being developed by the University of Oxford and manufactured by the Serum Institute of India (SII), began today at the Sassoon General Hospital, administered for the state, in Pune, Maharashtra on Monday, a senior …
Read More »
“Cadila and Bharat Biotech have completed phase I trials. Serum Institute has completed phase II-B3 trials and will begin phase III trial (with 1,500 patients at 14 locations) after authorizations,” said Balram Bhargava, DG. , ICMR. Phase I clinical trials have revealed “excellent safety” of the two candidate vaccines developed …
Read More »
“It will take four to five years for everyone on this planet to get the vaccine,” Poonawalla told the Financial Times. The CEO of the world’s largest vaccine manufacturer has estimated that if the Covid-19 injection is a two-dose vaccine, like measles or rotavirus, the world will need 15 billion …
Read More »
MUMBAI / LONDON: The Serum Institute of India has suspended trials of AstraZeneca’s Covid-19 vaccine candidate until the British drugmaker restarts trials, Serum said on Thursday. “We are reviewing the situation and stopping the trials in India,” Serum said in a short statement. AstraZeneca said Tuesday that it had halted …
Read More »
The Serum Institute of India said it will halt the Phrase 3 trials that were due to start in India next week. New Delhi: The Serum Institute of India, which is manufacturing the Covishield coronavirus vaccine being developed by the University of Oxford in conjunction with major pharmaceutical company AstraZenca, …
Read More »